Jamey R. Skillings, MD | Authors

17700 SE 272ND ST

Articles

5-FU or UFT Combined With Leucovorin for Previously Untreated Metastatic Colorectal Cancer

September 02, 1997

This phase III study compares leucovorin plus fluorouracil (5-FU) 425 mg/m2, days 1 through 5, 28-day cycle, with oral leucovorin plus oral UFT (tegafur and uracil) 300 mg/m2, days 1 through 28, 35-day cycle, in terms of